Bright Minds Biosciences to Present at the Virtual H.C. Wainwright 23rd Annual Global Investment Conference; Shares Now Eligible for DTC Clearance
September 08, 2021 06:50 ET
|
Bright Minds Biosciences
VANCOUVER, British Columbia, Sept. 08, 2021 (GLOBE NEWSWIRE) -- Bright Minds Biosciences (“Bright Minds,” “BMB” or the “Company”) (CSE: DRUG) (OTCQB: BMBIF), a biotechnology company focused on...
Bright Minds Biosciences (“BMB”) Proprietary 5-HT2C Agonist Shows Significant Reduction in Seizure Activity
August 18, 2021 07:00 ET
|
Bright Minds Biosciences
-- BMB proprietary 5-HT2C agonist, BMB-101, shows efficacy in pre-clinical models of Dravet Syndrome/Epilepsy, with lower seizure duration and frequency -- -- Effect of BMB compounds was...
Bright Minds Biosciences Announces Application to List on Nasdaq
June 16, 2021 06:50 ET
|
Bright Minds Biosciences
VANCOUVER, British Columbia, June 16, 2021 (GLOBE NEWSWIRE) -- Bright Minds Biosciences (“Bright Minds,” “BMB” or the “Company”) (CSE: DRUG) (OTCQB: BMBIF), a biotechnology company focused on...
Bright Minds Biosciences Appoints New Board Member and Expands Leadership Team
June 14, 2021 16:05 ET
|
Bright Minds Biosciences
VANCOUVER, British Columbia, June 14, 2021 (GLOBE NEWSWIRE) -- Bright Minds Biosciences (“Bright Minds,” “BMB” or the “Company”) (CSE:DRUG) (OTCQB:BMBIF), a biotechnology company focused on...
Bright Minds Biosciences to Present at the H.C. Wainwright Virtual Conference Psychedelics in Psychiatry and Beyond
June 11, 2021 08:00 ET
|
Bright Minds Biosciences
VANCOUVER, British Columbia, June 11, 2021 (GLOBE NEWSWIRE) -- Bright Minds Biosciences (“Bright Minds,” “BMB” or the “Company”) (CSE:DRUG) (OTCQB:BMBIF), a biotechnology company focused on...
Bright Minds Biosciences to Present at the 2021 LD Micro Invitational XI
June 09, 2021 16:30 ET
|
Bright Minds Biosciences
VANCOUVER, British Columbia, June 09, 2021 (GLOBE NEWSWIRE) -- Bright Minds Biosciences (“Bright Minds,” “BMB” or the “Company”) (CSE:DRUG) (OTCQB:BMBIF), a biotechnology company focused on...
Bright Minds Biosciences Shares to Commence Trading on the OTCQB Venture Market on May 17, 2021
May 17, 2021 06:50 ET
|
Bright Minds Biosciences
VANCOUVER, British Columbia, May 17, 2021 (GLOBE NEWSWIRE) -- Bright Minds Biosciences (“Bright Minds,” “BMB” or the “Company”) (CSE:DRUG) (OTCQB:BMBIF), a biotechnology company focused on...
Bright Minds Biosciences to Present at the Benzinga Global Small Cap Conference
May 11, 2021 08:00 ET
|
Bright Minds Biosciences
VANCOUVER, British Columbia, May 11, 2021 (GLOBE NEWSWIRE) -- Bright Minds Biosciences (“Bright Minds,” “BMB” or the “Company”) (CSE:DRUG), a biotechnology company focused on developing novel...
Bright Minds Biosciences Appoints Industry Experts for Key Roles and Expands Scientific Advisory Team
April 27, 2021 08:00 ET
|
Bright Minds Biosciences
VANCOUVER, British Columbia, April 27, 2021 (GLOBE NEWSWIRE) -- Bright Minds Biosciences (“Bright Minds” or the “Company”), a biotechnology company focused on developing novel transformative...
Bright Minds Biosciences Announces Closing of $25.9 Million Unit Offering
March 17, 2021 12:30 ET
|
Bright Minds Biosciences
THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT AUTHORIZED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. VANCOUVER, British...